vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $38.5M, roughly 1.0× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs 24.7%, a 244.0% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs 81.3%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 51.0%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

CDXS vs ORC — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.0× larger
CDXS
$38.9M
$38.5M
ORC
Growing faster (revenue YoY)
ORC
ORC
+291.3% gap
ORC
372.6%
81.3%
CDXS
Higher net margin
ORC
ORC
244.0% more per $
ORC
268.7%
24.7%
CDXS
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
51.0%
CDXS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
ORC
ORC
Revenue
$38.9M
$38.5M
Net Profit
$9.6M
$103.4M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
24.7%
268.7%
Revenue YoY
81.3%
372.6%
Net Profit YoY
192.5%
1764.9%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
ORC
ORC
Q4 25
$38.9M
$38.5M
Q3 25
$8.6M
$26.9M
Q2 25
$15.3M
$23.2M
Q1 25
$7.5M
$19.7M
Q4 24
$21.5M
Q3 24
$12.8M
$340.0K
Q2 24
$8.0M
$-697.0K
Q1 24
$17.1M
$-2.5M
Net Profit
CDXS
CDXS
ORC
ORC
Q4 25
$9.6M
$103.4M
Q3 25
$-19.6M
$72.1M
Q2 25
$-13.3M
$-33.6M
Q1 25
$-20.7M
$17.1M
Q4 24
$-10.4M
Q3 24
$-20.6M
$17.3M
Q2 24
$-22.8M
$-5.0M
Q1 24
$-11.5M
$19.8M
Gross Margin
CDXS
CDXS
ORC
ORC
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
ORC
ORC
Q4 25
27.1%
Q3 25
-220.3%
Q2 25
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
Q3 24
-129.0%
Q2 24
-284.9%
Q1 24
-69.6%
Net Margin
CDXS
CDXS
ORC
ORC
Q4 25
24.7%
268.7%
Q3 25
-228.1%
267.8%
Q2 25
-86.6%
-145.0%
Q1 25
-274.3%
86.9%
Q4 24
-48.4%
Q3 24
-160.8%
5094.1%
Q2 24
-285.2%
714.3%
Q1 24
-67.4%
-794.2%
EPS (diluted)
CDXS
CDXS
ORC
ORC
Q4 25
$0.13
Q3 25
$-0.22
Q2 25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
Q3 24
$-0.29
Q2 24
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
ORC
ORC
Cash + ST InvestmentsLiquidity on hand
$78.2M
$665.9M
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$1.4B
Total Assets
$147.8M
$11.7B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
ORC
ORC
Q4 25
$78.2M
$665.9M
Q3 25
$58.7M
$583.9M
Q2 25
$66.3M
$440.8M
Q1 25
$59.8M
$396.4M
Q4 24
$73.5M
Q3 24
$90.3M
$322.1M
Q2 24
$73.2M
$241.0M
Q1 24
$85.5M
$190.4M
Total Debt
CDXS
CDXS
ORC
ORC
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
ORC
ORC
Q4 25
$50.5M
$1.4B
Q3 25
$38.5M
$1.1B
Q2 25
$55.6M
$912.0M
Q1 25
$49.6M
$855.9M
Q4 24
$66.9M
Q3 24
$73.4M
$656.0M
Q2 24
$61.4M
$555.9M
Q1 24
$79.3M
$481.6M
Total Assets
CDXS
CDXS
ORC
ORC
Q4 25
$147.8M
$11.7B
Q3 25
$124.0M
$9.1B
Q2 25
$138.2M
$7.6B
Q1 25
$128.9M
$7.3B
Q4 24
$149.0M
Q3 24
$148.2M
$5.9B
Q2 24
$132.0M
$4.9B
Q1 24
$149.6M
$4.2B
Debt / Equity
CDXS
CDXS
ORC
ORC
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
ORC
ORC
Operating Cash FlowLast quarter
$20.1M
$120.4M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
ORC
ORC
Q4 25
$20.1M
$120.4M
Q3 25
$-7.7M
$28.0M
Q2 25
$-18.0M
$18.4M
Q1 25
$-13.8M
$25.8M
Q4 24
$-16.5M
Q3 24
$-13.0M
$-14.8M
Q2 24
$-12.2M
$19.3M
Q1 24
$-7.8M
$45.0M
Free Cash Flow
CDXS
CDXS
ORC
ORC
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CDXS
CDXS
ORC
ORC
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CDXS
CDXS
ORC
ORC
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CDXS
CDXS
ORC
ORC
Q4 25
2.09×
1.16×
Q3 25
0.39×
Q2 25
Q1 25
1.51×
Q4 24
Q3 24
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons